Clinical trial
Investigation of Prognostic Biomarkers in Patients With Urothelial Carcinoma Treated With Platinum Regimens
NCT04872036 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Prognostic Biomarkers in Patients With Urothelial Carcinoma Treated With Platinum Regimens
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2000
- Completion date
- June 30, 2017
- Enrollment
- 66 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer